Literature DB >> 19141032

The expression profile of glypican-3 and its relation to macrophage population in human hepatocellular carcinoma.

Hirotake Takai1, Atsuhiko Kato, Chie Kato, Takeshi Watanabe, Koichi Matsubara, Masami Suzuki, Hiroaki Kataoka.   

Abstract

BACKGROUND: Glypican-3 (GPC3) is frequently upregulated in hepatocellular carcinoma (HCC). Analysis of GPC3-deficient mice implies GPC3 involvement in macrophage-lineage cells. AIM: In this study, we first assessed the association of GPC3 expression with the macrophage population in liver tissues from 30 HCC patients using immunohistochemistry.
METHODS: The GPC3 expression was categorized into three patterns - one with GPC3-negative staining and two with GPC3-positive staining (one with unclear membrane staining and one with clear membrane staining, designated GPC3+/C). The number of macrophages that were stained with resident macrophage (rMvarphi) or pan-macrophage (pMvarphi) markers was counted for each GPC3 expression pattern.
RESULTS: GPC3 immunoreactivity was observed in 76.7% of the HCC specimens. No significant differences were observed in the number of rMvarphi marker-positive cells among the three expression patterns. In contrast, the GPC3+/C pattern showed a significantly higher number of pMvarphi-positive cells compared with the other two patterns, most of which tended to take on the morphology of migrating macrophages. A second experiment conducted to compare macrophage infiltration between the xenograft tissues of a GPC3-transfected HCC cell line and its parent GPC3-nonexpressing cell line revealed that the increase in macrophages was stimulated by membrane expression of GPC3.
CONCLUSION: The observations suggest that the increased macrophages in the GPC3+/C pattern are likely to be recruited macrophages, not resident macrophages, and that the expression of GPC3 in the membrane is involved in macrophage recruitment.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19141032     DOI: 10.1111/j.1478-3231.2008.01968.x

Source DB:  PubMed          Journal:  Liver Int        ISSN: 1478-3223            Impact factor:   5.828


  15 in total

Review 1.  Glypican-3 is a prognostic factor and an immunotherapeutic target in hepatocellular carcinoma.

Authors:  Yukihiro Haruyama; Hiroaki Kataoka
Journal:  World J Gastroenterol       Date:  2016-01-07       Impact factor: 5.742

Review 2.  Role of tumor-associated macrophages in the progression of hepatocellular carcinoma.

Authors:  Ken Shirabe; Yohei Mano; Jun Muto; Rumi Matono; Takashi Motomura; Takeo Toshima; Kazuki Takeishi; Hidekaki Uchiyama; Tomoharu Yoshizumi; Akinobu Taketomi; Masaru Morita; Shunichi Tsujitani; Yoshihisa Sakaguchi; Yoshihiko Maehara
Journal:  Surg Today       Date:  2011-11-25       Impact factor: 2.549

3.  Early transcriptional responses of HepG2-A16 liver cells to infection by Plasmodium falciparum sporozoites.

Authors:  Rana Chattopadhyay; Patricia de la Vega; Sun H Paik; Yoko Murata; Earl W Ferguson; Thomas L Richie; Guck T Ooi
Journal:  J Biol Chem       Date:  2011-06-07       Impact factor: 5.157

Review 4.  The Role of Glypicans in Cancer Progression and Therapy.

Authors:  Nan Li; Madeline R Spetz; Mitchell Ho
Journal:  J Histochem Cytochem       Date:  2020-07-06       Impact factor: 2.479

Review 5.  Glypican-3: a new target for cancer immunotherapy.

Authors:  Mitchell Ho; Heungnam Kim
Journal:  Eur J Cancer       Date:  2010-11-26       Impact factor: 9.162

6.  Time-to-event modelling of effect of codrituzumab on overall survival in patients with hepatocellular carcinoma.

Authors:  Mikiko Nakamura; Chao Xu; Cheikh Diack; Norihisa Ohishi; Ruey-Min Lee; Satofumi Iida; Takehiko Kawanishi; Toshihiko Ohtomo; Ghassan K Abou-Alfa; Ya-Chi Chen
Journal:  Br J Clin Pharmacol       Date:  2018-03-09       Impact factor: 4.335

7.  The role of glypican-3 in regulating Wnt in hepatocellular carcinomas.

Authors:  Wei Gao; Mitchell Ho
Journal:  Cancer Rep       Date:  2011

8.  A bispecific antibody targeting GPC3 and CD47 induced enhanced antitumor efficacy against dual antigen-expressing HCC.

Authors:  Kaixin Du; Yulu Li; Juan Liu; Wei Chen; Zhizhong Wei; Yong Luo; Huisi Liu; Yonghe Qi; Fengchao Wang; Jianhua Sui
Journal:  Mol Ther       Date:  2021-01-09       Impact factor: 11.454

Review 9.  The inflammatory microenvironment in hepatocellular carcinoma: a pivotal role for tumor-associated macrophages.

Authors:  Daria Capece; Mariafausta Fischietti; Daniela Verzella; Agata Gaggiano; Germana Cicciarelli; Alessandra Tessitore; Francesca Zazzeroni; Edoardo Alesse
Journal:  Biomed Res Int       Date:  2012-12-30       Impact factor: 3.411

Review 10.  The role of macrophage polarization in infectious and inflammatory diseases.

Authors:  Adam C Labonte; Annie-Carole Tosello-Trampont; Young S Hahn
Journal:  Mol Cells       Date:  2014-03-12       Impact factor: 5.034

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.